| 000 | 01649 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518043944.0 | ||
| 264 | 0 | _c20200825 | |
| 008 | 202008s 0 0 eng d | ||
| 022 | _a1582-4934 | ||
| 024 | 7 |
_a10.1111/jcmm.14493 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZheng, Zongyu | |
| 245 | 0 | 0 |
_a4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement. _h[electronic resource] |
| 260 |
_bJournal of cellular and molecular medicine _c08 2019 |
||
| 300 |
_a5771-5781 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAMP-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 |
_aDiabetic Cardiomyopathies _xcomplications |
| 650 | 0 | 4 | _aFibrosis |
| 650 | 0 | 4 |
_aInflammation _xblood |
| 650 | 0 | 4 |
_aLignans _xpharmacology |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 700 | 1 | _aMa, Tianjiao | |
| 700 | 1 | _aGuo, Hua | |
| 700 | 1 | _aKim, Ki Soo | |
| 700 | 1 | _aKim, Kyoung Tae | |
| 700 | 1 | _aBi, Liqi | |
| 700 | 1 | _aZhang, Zhiguo | |
| 700 | 1 | _aCai, Lu | |
| 773 | 0 |
_tJournal of cellular and molecular medicine _gvol. 23 _gno. 8 _gp. 5771-5781 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcmm.14493 _zAvailable from publisher's website |
| 999 |
_c29798314 _d29798314 |
||